FDA Approves Skyclarys

FDA Approves Skyclarys (omaveloxolone) for the Treatment of Friedreich’s Ataxia PLANO, Texas–(BUSINESS WIRE) February 28, 2023 — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” […]

Read more
1 2 3 16